Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027 by Burns, David A. et al.
Reconsidering the Sporulation Characteristics of
Hypervirulent Clostridium difficile BI/NAP1/027
David A. Burns
., Daniela Heeg
., Stephen T. Cartman, Nigel P. Minton*
Clostridia Research Group, School of Molecular Medical Sciences, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, United Kingdom
Abstract
Clostridium difficile is the leading cause of antibiotic-associated diarrhoea and a major burden to healthcare services
worldwide. In recent years, C. difficile strains belonging to the BI/NAP1/027 type have become highly represented among
clinical isolates. These so-called ‘hypervirulent’ strains are associated with outbreaks of increased disease severity, higher
relapse rates and an expanded repertoire of antibiotic resistance. Spores, formed during sporulation, play a pivotal role in
disease transmission and it has been suggested that BI/NAP1/027 strains are more prolific in terms of sporulation in vitro
than ‘non-epidemic’ C. difficile types. Work in our laboratory has since provided credible evidence to the contrary suggesting
that the strain-to-strain variation in C. difficile sporulation characteristics is not type-associated. However, the BI/NAP1/027
type is still widely stated to have an increased rate of sporulation. In this study, we analysed the sporulation rates of 53 C.
difficile strains, the largest sample size used to-date in such a study, including 28 BI/NAP1/027 isolates. Our data confirm that
significant variation exists in the rate at which different C. difficile strains form spores. However, we clearly show that the
sporulation rate of the BI/NAP1/027 type was no higher than that of non-BI/NAP1/027 strains. In addition, we observed
substantial variation in sporulation characteristics within the BI/NAP1/027 type. This work highlights the danger of assuming
that all strains of one type behave similarly without studying adequate sample sizes. Furthermore, we stress the need for
more rigorous experimental procedures in order to quantify C. difficile sporulation more accurately in the future.
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Introduction
Clostridium difficile, a Gram-positive, spore-forming bacterium, is
the major underlying cause of antibiotic-associated diarrhoea.
Outbreaks of C. difficile infection (CDI) have led to patient
isolation, ward closures and, sometimes, hospital closure. In the
United States of America alone, CDI is estimated to affect over
500,000 people each year and cost the healthcare system over $3
billion per year [1,2]. Endospores, formed during sporulation, are
able to resist a variety of industrial cleaning agents and can persist
on surfaces in healthcare settings for prolonged periods of time
[3,4]. Following ingestion by susceptible individuals, spores return
to vegetative cell growth through germination which allows for
colonisation and production of the characteristic toxins [5].
Consequently, CDI can cause intestinal perforation, toxic
megacolon and a potentially fatal pseudo-membranous colitis
[6]. The spore form of C. difficile is, therefore, crucial for disease
transmission.
The challenge of CDI has increased with the emergence of so-
called ‘hypervirulent’ strains belonging to restriction endonuclease
type BI, North American pulsed-field type 1 and PCR-ribotype
027 (BI/NAP1/027). Strains of the BI/NAP1/027 type have
become highly represented among clinical isolates from recent
outbreaks and are associated with an expanded repertoire of
antibiotic resistance, more severe disease and higher relapse rates
[7,8]. Unsurprisingly, there is widespread interest in understand-
ing the underlying factors that have led to the emergence of strains
such as those of the BI/NAP1/027 type.
Some BI/NAP1/027 strains are believed to produce higher
levels of toxin in the laboratory than strains belonging to other
types [9] and a number of recent studies have concluded that
strains of the BI/NAP1/027 type are also more prolific in terms of
sporulation in vitro [10,11,12,13,14,15]. However, work in our
laboratory has since provided credible evidence to the contrary
suggesting that the strain-to-strain variation in C. difficile
sporulation characteristics is not type-associated [16,17]. In spite
of this evidence, the BI/NAP1/027 type is still widely stated to
have an increased rate of sporulation [1,18,19,20]. On analysis of
the other studies currently in the literature, it is apparent that
sample sizes have remained small and, perhaps most importantly,
the methods used to quantify sporulation have severe limitations
[21].
Previous studies have varied in the choice of growth medium,
the time over which sporulation was measured and the procedures
used for expressing sporulation rates [11,12,13,14,15]. For
example, some studies have expressed sporulation as the ratio of
spores to vegetative cells within the population [11,12,15].
However, this relative measure can be affected by growth
differences among strains and also by the survival of non-
sporulating vegetative cells. Another study enumerated spore titres
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treatment, a measure that cannot distinguish between sporulation,
ethanol resistance, or spore germination and outgrowth [14].
Finally, a recent study expressed sporulation as the proportion of
CFU recovered following exposure to aerobic conditions [10].
Unfortunately, there is no evidence present in the literature to-date
describing whether exposure of C. difficile vegetative cells to oxygen
has a bacteriostatic or bacteriocidal effect, calling into question the
conclusions of the authors.
Our previous analysis of C. difficile sporulation included seven
BI/NAP1/027 strains, including isolates from both North
America or Europe to minimise the risk of sampling clonal strains
[16]. The diversity we observed within one group of seven C.
difficile strains suggests that, in order to accurately determine
variation in sporulation between different groups, an appropriate
sample size will need to be much larger than seven strains.
However, while the sample used in our study was not particularly
large, this did represent the largest sample size used to-date in such
a study. Other reports of C. difficile sporulation rates have been
limited to as few as one representative strain of each type [14,15].
Consequently, the continued use of small sample sizes may be
contributing to the conflicting evidence that is currently present in
the literature.
In this study, we sought to clarify how the sporulation rates of C.
difficile BI/NAP1/027 strains compare to isolates of other types.
We analysed 53 strains of C. difficile isolated in the USA, Canada
and Europe, including 28 BI/NAP1/027 and 25 non-BI/NAP1/
027 strains (Table 1). Notably, this is the largest sample size used to
date in a study on C. difficile sporulation. Substantial diversity was
observed in the rate of C. difficile sporulation among isolates but,
importantly, this diversity did not correlate to type. Crucially, the
BI/NAP1/027 type was not found to have a higher sporulation
capacity than strains of other types.
Results
Comparison of the growth rates of C. difficile isolates
Variations in growth kinetics among different isolates may affect
subsequent sporulation characteristics. To ensure that any future
observations of sporulation rates were not a result of growth
differences among strains, the change in optical density at 600nm
(OD600) was measured over a 20 h time period. During the first
12 h there was no obvious difference in growth among C. difficile
strains (data not shown). Therefore, based on the observed growth
kinetics, we can exclude generic growth differences when
interpreting subsequent sporulation data. Interestingly, after 20 h
(Fig. 1) there was a significant difference in cell density among all
strains of C. difficile (p,0.0001). In addition, the cell density at 20 h
of the non-BI/NAP1/027 group was 24% higher than BI/NAP1/
027 strains (p,0.0001). This finding is contrary to previous studies
which, intriguingly, have reported that BI/NAP1/027 strains
exhibited a higher cell density at 24 h than non-BI/NAP1/027
strains [9,11].
Ensuring minimal spore counts on inoculation of the
sporulation medium
For studies of sporulation over a defined time-period (i.e. the
rate of sporulation), it is crucial that the number of spores in the
culture at 0 h are minimal, so as not to mis-interpret the
subsequent spore counts. In preliminary work, we noted that five
of the selected BI/NAP1/027 strains (DH478, DH1858, DH361,
027 Alexander and 51557) produced heat-resistant CFU counts in
excess of 10
4 CFU/ml (data not shown) at 0 h. Excessive carryover
of spores from previous passages would suggest that sporulation
has been initiated within the culture prior to the start of the
experiment. This may in turn affect the rate of subsequent
sporulation when compared to a culture where no spores are
present at 0 h and could, consequently, lead to a bias among spore
counts. Therefore, to ensure that as few spores as possible were
present at 0 h, fresh stocks of the aforementioned strains were sub-
cultured on rich medium supplemented with the bile salt
taurocholate, to induce germination of any spores present in the
culture [22,23]. Following inoculation of the sporulation medium
with these fresh cultures, fewer heat-resistant CFU were observed
at 0 h (Fig. 2A) confirming that the high levels of heat-resistant
CFU observed previously at 0 h were due to the presence of
spores. This observation shows that an initial measurement at 0 h
is essential to ensure that sporulation is observed only during the
desired time period.
Comparison of sporulation rates of BI/NAP1/027 and
non-BI/NAP1/027 strains
The development of heat-resistant CFU was measured over a
120 h time period in order to understand the rate at which these
isolates formed spores. Heat-resistant CFU were enumerated at
0 h, 24 h, 48 h and 120 h. A significant difference in the observed
heat-resistant CFU was noted within the group of 53 strains at
24 h and 48 h (Fig. 2, panels B and C). After 24 h of growth,
although the BI/NAP1/027 group appeared to form fewer heat-
resistant CFU than the non-BI/NAP1/027 group the difference in
heat-resistant CFU was not found to be statistically significant
(p=0.053). However, at 48 h the numbers of heat-resistant CFU
were significantly higher in the non-BI/NAP1/027 group
(p=0.044). Interestingly, at 120 h there were no significant
differences in the total amount of heat-resistant CFU observed
among the group of 53 strains (Fig. 2D). Taken together, these
data show that there is substantial variation in the rate at which
different C. difficile strains form spores. However, this variation
does not appear to be strictly associated with type and, most
importantly, the rate of heat-resistant CFU development in BI/
NAP1/027 strains does not appear to be higher than non-BI/
NAP1/027 isolates.
By definition, a heat-resistant CFU is a vegetative cell that has
successfully completed sporulation, resisted the heat treatment,
completed germination and, finally, returned to vegetative cell
growth. Therefore, to accurately compare the number of spores
independently of these other factors, one must enumerate spores
using phase-contrast microscopy. To compare the spore titres
among C. difficile strains, we enumerated spores of all 53 strains by
microscopy, after 120 h of growth. Samples were taken from the
same cultures used to measure heat-resistant CFU and the number
of spores per field of view was counted at 1.5640x magnification.
We observed a significant difference in spore titre among the 53
strains (p,0.0001) but no significant difference (p=0.18) was
observed between the BI/NAP1/027 and non-BI/NAP1/027
groups (Fig. 3). These data show that although there is significant
strain-to-strain variation in the total spore titres of different C.
difficile strains, this variation does not appear to correlate to type.
Furthermore, the BI/NAP1/027 strains did not have a higher
sporulation capacity than the non-BI/NAP1/027 strains. It was
intriguing that there was a statistical significance in the variation of
spore titres among the 53 C. difficile isolates, as determined by
microscopy, yet the corresponding variation in numbers of heat-
resistant CFU at 120 h was not found to be statistically significant.
The most obvious explanation for this finding is that the
proportion of spores that form colonies may vary from strain to
strain, a phenomenon that we have previously observed [16]. This
suggests that differences may exist in spore heat resistance and/or
Sporulation of Clostridium difficile
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Strain name PCR-ribotype Country Source / Reference
001-2 001 The Netherlands Ed Kuijper
001-3 001 The Netherlands Ed Kuijper
001-5 001 The Netherlands Ed Kuijper
001-7 001 The Netherlands Ed Kuijper
CD 16839 002 Hungary Ed Kuijper
8083598 002 The Netherlands Ed Kuijper
8085053 002 The Netherlands Ed Kuijper
8092419 002 The Netherlands Ed Kuijper
9001966 002 The Netherlands Ed Kuijper
MF081988 002 Ireland Ed Kuijper
VPI10463 003 [26]
675,1 017 Romania Ed Kuijper
81568 027 France Ed Kuijper
5108111 027 The Netherlands Ed Kuijper
32219 027 Luxembourg Ed Kuijper
M246 027 Ireland Ed Kuijper
2191 027 Ireland Ed Kuijper
51556 027 Germany Ed Kuijper
60902 027 Switzerland Ed Kuijper
26131 027 Finland Ed Kuijper
CDC 32 027 USA (historical) [27]
CDC 38 027 USA [27]
M13042 027 Canada [27]
DH349 027 East of England, Cambridge, UK Val Hall
DH320 027 NE England, Newcastle, UK Val Hall
DH1916 027 SW England, Torbay, UK Val Hall
DH1396 027 SE England, Slough, UK Val Hall
DH1432 027 London, Barnet, UK Val Hall
DH1834 027 East of England, Ipswich, UK Val Hall
DH1466 027 East Midlands, Northampton, UK Val Hall
DH1751 027 Yorkshire & Humberside, Bradford, UK Val Hall
027 Alexander 027 Austria Ed Kuijper
DH1858 027 NE England,Sunderland, UK Vall Hall
51557 027 Germany Ed Kuijper
DH478 027 SW England, Taunton, UK Val Hall
DH361 027 London, Lewisham, UK Val Hall
DH131 027 NW England, Manchester, UK Val Hall
R20352 027 Canada Val Hall
R12087 027 Historical EU strain (mid 80s) Val Hall
R20291 027 Stoke Mandeville, UK Jon Brazier
Wilcox 078 078 Leeds, UK Mark Wilcox
31662 078 The Netherlands Ed Kuijper
2016 078 Ireland Ed Kuijper
7004578 078 The Netherlands Ed Kuijper
7009825 078 The Netherlands Ed Kuijper
R9764 081 Cardiff, UK Jon Brazier/Ed Kuijper
R10432 106 Birmingham, UK Val Hall
R12801 106 Bristol, UK Val Hall
R15347 106 London, UK Val Hall
R22079 106 Sheffield, UK Val Hall
Sporulation of Clostridium difficile
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which might be of interest for future studies.
Diversity in sporulation rate within the BI/NAP1/027 type
Despite the continued use of small sample sizes, many previous
studies have drawn general conclusions about the sporulation
characteristics of the BI/NAP1/027 type. When comparing the
numbers of heat-resistant CFU at 24 h, we observed significant
diversity (p=0.0009) within the BI/NAP1/027 group (Fig. 2B)
although this did not correspond with the geographical regions of
isolation. We noted significant differences in heat-resistant CFU
observed at 24 h within the group of BI/NAP1/027 strains
isolated in the United Kingdom (p=0.032) but not within the
group of BI/NAP1/027 strains isolated from the rest of Europe
(p=0.17). This indicates that even within a small geographical
region such as the United Kingdom, substantial diversity can still
exist between different BI/NAP1/027 strains, in terms of
sporulation characteristics.
Discussion
Spores are considered to be the vehicles of transmission of CDI
[4]. Strains found to have an increased sporulation capacity are,
therefore, of particular concern. In spite of our previous work
suggesting that the variation in C. difficile sporulation rates is not
associated with type [16], the suggestion that hypervirulent C.
difficile types have a greater sporulation capacity than other types
continues to circulate at international meetings, as well as in print
[1,10,14,18,19,20]. Here, we used an accurate, reproducible set of
procedures to explore the sporulation properties of C. difficile
isolates using the largest sample size to-date. Our comparison of 53
C. difficile isolates clearly indicates that neither the sporulation rate,
nor the total sporulation capacity of the BI/NAP1/027 type were
higher than that of non-BI/NAP1/027 strains. Indeed, our data
suggest that the tested BI/NAP1/027 strains may form spores at a
slower rate than the tested non-BI/NAP1/027 over 48 h.
We have previously reasoned that the current literature contains
insufficient evidence to conclude that C. difficile BI/NAP1/027
strains exhibit an increased in vitro sporulation capacity [16,17,21].
When comparing the previous literature to the work from our
laboratory, it is apparent that the different conclusions may reflect
differences in the experimental approach. Importantly, when taking
into account the different procedures used in other studies to
measuresporulation,threepreviouslypublishedstudiesincludedthe
same C. difficile strain in their analysis, VPI 10463 [11,13,14]. These
studies concluded that VPI 10463 is a low-sporulating strain,
although both this study (Fig. 2 and Fig. 3) and our previous work
are in disagreement with that conclusion [16]. These contradicting
Strain name PCR-ribotype Country Source / Reference
R23942 106 Cambridge, UK Val Hall
R25469 106 Antrim, Northern Ireland Val Hall
R10459 106 Cardiff, UK Jon Brazier/Ed Kuijper
doi:10.1371/journal.pone.0024894.t001
Table 1. Cont.
Figure 1. The cell density of C. difficile isolates in BHIS broth after 20 h measured as OD600. The BI/NAP1/027 strains were originally
isolated from North America (N.A.), the UK, or the rest of Europe. The data represent the average of three independent experiments and error bars
indicate standard errors of the means. The solid line represents the average OD600 of all 53 isolates at 20h, the dotted line represents the average
OD600 of the BI/NAP1/027 group, and the dashed line represents the average OD600 of the non-BI/NAP1/027 group.
doi:10.1371/journal.pone.0024894.g001
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methods that cannot quantify sporulation independently of other
important properties. Previously, we have introduced an experi-
mental design that is capable of distinguishing between factors such
as (i) vegetative cell growth; (ii) sporulation rate; (iii) total
sporulation; (iv) the fate of non-sporulating vegetative cells; (v)
spore stress resistance; and (vi) spore germination and outgrowth
[16,21]. By measuring sporulation over a period of at least 120 h it
is possible to obtain an accurate account of the total number of
spores produced and by taking measurements at multiple time-
points, informed comments can be made on the rate of sporulation.
Additionally, in order to make accurate statements relating to the
absolute number of spores, exact spore titres must be enumerated
using phase-contrast microscopy. Finally, suitable controls are
essential to ensure that sporulation is observed only over the defined
time-period and to ensure that the data are not inadvertently biased
or skewed by technical errors.
The experiments conducted in this study underline the
importance of ensuring minimal spore titres are present at the start
of the assay. By measuring heat-resistant CFU at 0 h, we identified
substantial carryover of spores into the sporulation medium in five
C. difficile strains. Subsequent sub-culturing of these strains on
appropriate media noticeably decreased the initial heat-resistant
CFUcountwhentheexperimentwasrepeated.Thedevelopmentof
spores in a liquid culture cannot be judged accurately without a
measurement at 0 h as spores carried over from the starter culture
may influence the rate of sporulation over a defined time period.
Only one other study outside of our laboratory has included such a
measurement of sporulation at 0 h [14], suggesting that some
previous studies may not have analysed sporulation rates consis-
tently within their sample of strains. In addition, no study outside of
our laboratory has included a sporulation-negative control when
measuring C. difficile sporulation rates. This is a fundamental
control, as simple errors in experimental technique can lead to
contamination of sporulation cultures which may affect subsequent
spore counts. An ideal sporulation-negative control is a spo0A
mutant, where the master regulator of sporulation has been
inactivated, and this strain is available upon request from our
laboratory [24]. Therefore, the lack of appropriate controls in a
number of previous studies may perhaps make it difficult to validate
the results [10,11,12,13,14,15].
We also observed substantial diversity in sporulation rates within
the BI/NAP1/027 type. For this reason, it seems obvious that all
future C. difficile strain comparisons, not only those studying
sporulation rates, should be based on as large a sample as possible.
Furthermore, when describing a group of strains such as those
belonging to the BI/NAP1/027 type, it seems advisable not to
assume that the characteristics of one (or a small number of strains)
is representative of all strains in that group. Indeed, recent evidence
has suggested that patients infected with C. difficile BI/NAP1/027
were not any more likely to develop ‘‘severe’’ disease than patients
infected with other PCR-ribotypes [25]. Therefore, we propose that
Figure 2. Development of heat-resistant CFU of 53 C. difficile strains. CFU following heat treatment (60uC for 25 min) were determined after
(A) 0h; (B) 24h; (C) 48h; and (D) 120h incubation in BHIS broth. The BI/NAP1/027 strains were originally isolated from North America (N.A.), the UK, or
the rest of Europe. The data represent the average of three independent experiments and error bars indicate the standard errors of the means. The
solid line represents the average CFU/ml of all 53 isolates at 20h, the dotted line represents the average CFU/ml of the BI/NAP1/027 group, and the
dashed line represents the average CFU/ml of the non-BI/NAP1/027 group. The detection limit for colony counts was 50 CFU/ml.
doi:10.1371/journal.pone.0024894.g002
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thismay not be the case forallstrainsof theBI/NAP1/027 type. To
the contrary, individual C. difficile strains belonging to other types
may well be as virulent as BI/NAP1/027 strains.
Further studies of C. difficile sporulation diversity are clearly
needed. Such studies could examine sporulation efficiency by
measuring the proportion of vegetative cells that form spores.
Additionally, by observing the numbers of vegetative cells in a
sporulating culture an argument could then be made regarding the
fate of vegetative cells that do not enter the sporulation process.
The obvious question then still remains of how the in vitro
sporulation characteristics described in this study relate to
sporulation proficiency in vivo. Consequently, until our under-
standing of C. difficile sporulation and germination in vivo improves,
it will be difficult to associate the in vitro characteristics observed in
this study with disease severity.
The emergence of some C. difficile BI/NAP1/027 strains
associated with increased disease severity provides continuing
challenges in the healthcare setting. Understanding how sporula-
tion rates vary among clinical isolates of C. difficile is a small but
essential step to understanding how emerging, hypervirulent C.
difficile types differ from those which are less frequently associated
with outbreaks of severe disease. Based upon the data presented in
this manuscript and the limitations of some previous studies, it is
possible that current research directions associated with the
sporulation mechanisms of C. difficile may be based on incorrect
interpretations of preliminary data.
Materials and Methods
Bacterial strains and culture conditions
A total of 28 BI/NAP1/027 and 25 non-BI/NAP1/027 strains
of C. difficile were chosen for analysis (Table 1). The BI/NAP1/027
group included isolates from the United Kingdom (n=13),
mainland Europe (n=11) and North America (n=4). The non-
BI/NAP1/027 group included strains isolated in Europe belong-
ing to PCR-ribotypes 001 (n=4), 002 (n=6), 003 (n=1), 017
(n=1), 078 (n=5), 081 (n=1) and 106 (n=7).
C. difficile strains were grown at 37uC in an anaerobic
workstation (Don Whitley, United Kingdom) in BHIS (brain
heart infusion supplemented with yeast extract [5 mg/ml, Oxoid]
and L-cysteine [0.1%, Sigma, United Kingdom]) broth or agar, in
which C. difficile sporulates efficiently [23].
Preparation of C. difficile spores
C. difficile strains were selected on BHIS agar supplemented with
cefoxitin (8 mg/ml) and cycloserine (250 mg/ml). Sporulation of C.
difficile was achieved through incubation of cultures in BHIS broth
in anaerobic conditions at 37uC for 5 days. Overnight cultures of
C. difficile isolates in BHIS broth were used to inoculate a starter
culture in BHIS broth 1 in 100, which was grown to an OD600 of
between 0.2 and 0.5 to ensure the lack of spores on inoculation of
the sporulation medium. The sporulation medium was then
inoculated 1 in 100 with the starter culture.
Measurement of sporulation rates
In order to measure colony formation, 500 ml samples of the
sporulation medium were removed from the anaerobic chamber
and heated at 60uC for 25 min to kill vegetative cells but not
spores. Samples were then returned to the anaerobic chamber,
serially diluted in phosphate buffer saline and plated onto BHIS
agar supplemented with the bile salt taurocholate (0.1%, Sigma,
United Kingdom) to induce germination and enhance recovery of
C. difficile spores [22,23]. Plates were incubated for 24 h before
CFU were enumerated. For all measurements of heat-resistant
Figure 3. Total spore counts enumerated by phase-contrast microscopy after 120 h incubation in BHIS broth, from the same
cultures used to measure heat-resistant CFU. The BI/NAP1/027 strains were originally isolated from North America (N.A.), the UK, or the rest of
Europe. Spore titres were expressed as the number of spores per field of view. The data represent the average of three independent experiments and
error bars indicate the standard error of the means. The solid line represents the average spore count of all 53 isolates at 20h, the dotted line
represents the average spore count of the BI/NAP1/027 group, and the dashed line represents the average spore count of the non-BI/NAP1/027
group.
doi:10.1371/journal.pone.0024894.g003
Sporulation of Clostridium difficile
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technical errors [24].
Measurement of total sporulation capacities
Total sporulation after 5 days incubation in BHIS was assayed
by counting spores under phase contrast microscopy. After 120 h
growth, a 10 mL aliquot of the sporulation medium was loaded
onto a microscopy slide, air dried, and visualised at 1.5640x
magnification. Sporulation was expressed as the number of spores
counted per field of view and a minimum of four fields of view
were counted for each replicate. Spores were enumerated under
live fields of view to allow for continuous z-plane adjustments and,
therefore, to ensure that all phase-bright spores in the field were
identified and counted.
Biological replicates and statistical analyses
All data presented in this manuscript represent the results of
three independent experiments. All statistical analysis was carried
out in GraphPad Prism using Student’s t-test for comparison of the
BI/NAP1/027 group with the non-BI/NAP1/027 group and one-
way analysis of variance with Tukey’s post hoc compensation for
multiple comparisons of individual strains.
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